Home Cart 0 Sign in  

[ CAS No. 38427-94-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 38427-94-0
Chemical Structure| 38427-94-0
Structure of 38427-94-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 38427-94-0 ]

Related Doc. of [ 38427-94-0 ]

Alternatived Products of [ 38427-94-0 ]

Product Details of [ 38427-94-0 ]

CAS No. :38427-94-0 MDL No. :MFCD03411622
Formula : C10H14N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ORUGTGTZBRUQIT-UHFFFAOYSA-N
M.W : 194.23 Pubchem ID :11206349
Synonyms :

Calculated chemistry of [ 38427-94-0 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 54.48
TPSA : 51.22 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.06 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.11
Log Po/w (XLOGP3) : 2.0
Log Po/w (WLOGP) : 2.24
Log Po/w (MLOGP) : 1.24
Log Po/w (SILICOS-IT) : 1.12
Consensus Log Po/w : 1.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.36
Solubility : 0.853 mg/ml ; 0.00439 mol/l
Class : Soluble
Log S (Ali) : -2.7
Solubility : 0.386 mg/ml ; 0.00199 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.98
Solubility : 0.204 mg/ml ; 0.00105 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.23

Safety of [ 38427-94-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280 UN#:N/A
Hazard Statements:H302-H317 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38427-94-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38427-94-0 ]
  • Downstream synthetic route of [ 38427-94-0 ]

[ 38427-94-0 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 38427-94-0 ]
  • [ 7521-41-7 ]
Reference: [1] Heterocyclic Communications, 2011, vol. 17, # 1-2, p. 21 - 23
  • 2
  • [ 504-29-0 ]
  • [ 24424-99-5 ]
  • [ 38427-94-0 ]
YieldReaction ConditionsOperation in experiment
94% at 100℃; for 0.0833333 h; Microwave irradiation; Green chemistry General procedure: Amine (1 mmol) and di-tert-butyl dicarbonate [(Boc)2O] (1.1 mmol) were placed in a microwave reaction vial. The LG microwave oven MG 555f was programmed to 300 W at 100 °C. The reaction was monitored using TLC. After the reaction, ice water was added to the reaction mixture which resulted in the precipitation of the product. The solid product was merely filtered off and washed with excess cold water. The product was pure enough for all practical purposes. For characterization purpose, it was further purified by column chromatography (Neutral Alumina as adsorbent, solvent system: Hexane: Ethyl acetate (7.5:2.5)).#10;
91% at 20℃; for 3.5 h; Inert atmosphere To 2-aminopyridine (100 mg, 1.06 mmol) was added a solution of Boc2O (270 μL, 1.17 mmol)in t-BuOH (8.5 mL) under argon atmosphere. After stirring at rt for 3.5 h, the mixture was concentrated by rotary evaporation to afford the crude product as a light yellow solid.Purification by column chromatography (5:1 → 3:1 → 1:1 hexanes/EtOAc) yielded S1u (187mg, 91percent) as a white solid.
74% at 20℃; for 16 h; General procedure: Boc2O (1.0 mmol) was added to a mixture of phenol or amine (1.0 mmol) andMgBr2 · OEt2 (0.1 mmol) in a round-bottom flask, at which point an evolution of gas occurs, and the reaction mixture was stirred magnetically at room temperature (ifnecessary, reactions was heated to∼60 °C). After complete consumption of the phenolor amine (by thin-layer chromatography, TLC; 3–16 h), the reaction mixture wasdiluted with water and extracted with EtOAc (3 × 20mL), and the combined EtOAcextracts were dried with Na2SO4 and concentrated under vacuum rotary evaporation.The residue was isolated by column chromatography through a bed of silicagel and eluted with 5–30percent ethyl acetate in hexane to afford the desired Bocprotectedproduct.
60% for 12 h; Heating / reflux Reference Example 80
tert-Butyl 2-pyridylcarbamate
2-Aminopyridine (6.0 g, 63.7 mmol) and di-tert-butyl dicarbonate (14.4 g, 65. 9 mol) were dissolved in tetrahydrofuran (150 ml), and the mixture was refluxed for 12 hrs..
After cooling, the precipitates were filtered, and the filtrate was concentrated..
The residue was subjected to a silica gel column chromatography..
The fractions eluted with hexane-ethyl acetate (15:1, v/v) were collected and concentrated to give the titled compound (7.5 g, 60 percent).1H-NMR (CDCl3) δ: 1.54 (9H, s), 6.94 (1H, m), 7.65 (1H, m), 7.96 (1H, d, J = 8.4 Hz), 8.29 (1H, d, J = 4.6 Hz), 8.70 (1H, br s).
51% at 20℃; for 24 h; Step 1 : fert-Butyl pyridin-2-ylcarbamate (9a)To a solution of (Boc)20 (218 g, 1.0 mol) in tert-butyl alcohol (1.5 L) was added 2-aminopyridine (94 g, 1.0 mol) slowly and the mixture was stirred at rt for 24 h, then concentrated under reduced pressure and purified by CC (PE/EA = 1/1) to give compound 9a (100 g, 51percent) as a white solid.
31.5% at 20℃; To the single-mouth bottle was added t-butanol (100 ml) and di-tert-butyl dicarbonate (51 g, 233.8 mmol).2-Aminopyridine (20 g, 212.5 mmol) was slowly added at room temperature and allowed to react at room temperature overnight.The reaction was monitored by spotting, and ethyl acetate (250 ml) was added, and water (100 ml) was extracted.The organic layer was washed with brine, dried over anhydrous magnesium sulfateResidue column chromatography (eluent is ethyl acetate: petroleum ether = 1:5 (v/v))Purified to 13g white solid,The yield was 31.5percent.

Reference: [1] Chemistry Letters, 2010, vol. 39, # 11, p. 1127 - 1129
[2] Journal of Organic Chemistry, 2002, vol. 67, # 14, p. 4965 - 4967
[3] RSC Advances, 2014, vol. 4, # 47, p. 24544 - 24550
[4] New Journal of Chemistry, 2018, vol. 42, # 12, p. 10142 - 10147
[5] Tetrahedron Letters, 2007, vol. 48, # 47, p. 8318 - 8322
[6] Tetrahedron Letters, 2008, vol. 49, # 16, p. 2527 - 2532
[7] Tetrahedron Letters, 2012, vol. 53, # 43, p. 5803 - 5806
[8] European Journal of Organic Chemistry, 2013, # 1, p. 35 - 39
[9] Tetrahedron Letters, 2010, vol. 51, # 49, p. 6388 - 6391
[10] RSC Advances, 2016, vol. 6, # 82, p. 78576 - 78584
[11] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 9, p. 2114 - 2124
[12] Organic Letters, 2012, vol. 14, # 17, p. 4386 - 4389
[13] Heterocyclic Communications, 2011, vol. 17, # 1-2, p. 21 - 23
[14] European Journal of Organic Chemistry, 2015, vol. 2015, # 19, p. 4214 - 4223
[15] Journal of Organic Chemistry, 2006, vol. 71, # 21, p. 8283 - 8286
[16] Synthetic Communications, 2015, vol. 45, # 5, p. 653 - 660
[17] Tetrahedron Letters, 2006, vol. 47, # 38, p. 6739 - 6742
[18] Journal of Organic Chemistry, 1998, vol. 63, # 21, p. 7258 - 7262
[19] Patent: EP1424336, 2004, A1, . Location in patent: Page 173
[20] Patent: WO2013/64231, 2013, A1, . Location in patent: Page/Page column 45
[21] Patent: CN108610283, 2018, A, . Location in patent: Paragraph 0095; 0096; 0097; 0098
[22] Tetrahedron Letters, 1994, vol. 35, # 48, p. 9003 - 9006
[23] Patent: WO2007/88041, 2007, A1, . Location in patent: Page/Page column 120-121
[24] Patent: US2009/82403, 2009, A1, . Location in patent: Page/Page column 58-59
[25] Patent: US2009/233883, 2009, A1, . Location in patent: Page/Page column 18
[26] Organic Letters, 2013, vol. 15, # 13, p. 3476 - 3479
[27] Letters in Organic Chemistry, 2013, vol. 10, # 1, p. 60 - 64
[28] Chemistry - An Asian Journal, 2013, vol. 8, # 12, p. 2970 - 2973
[29] Journal of Organic Chemistry, 2016, vol. 81, # 21, p. 10348 - 10356
  • 3
  • [ 96354-74-4 ]
  • [ 24424-99-5 ]
  • [ 38427-94-0 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 10, p. 2057 - 2059
  • 4
  • [ 24424-99-5 ]
  • [ 38427-94-0 ]
Reference: [1] Patent: WO2006/107851, 2006, A1, . Location in patent: Page/Page column 58
  • 5
  • [ 504-29-0 ]
  • [ 3282-30-2 ]
  • [ 38427-94-0 ]
Reference: [1] Patent: WO2006/52546, 2006, A2, . Location in patent: Page/Page column 84
  • 6
  • [ 504-29-0 ]
  • [ 34619-03-9 ]
  • [ 38427-94-0 ]
Reference: [1] Patent: US2008/275244, 2008, A1, . Location in patent: Page/Page column 12
  • 7
  • [ 504-29-0 ]
  • [ 24424-99-5 ]
  • [ 6268-43-5 ]
  • [ 38427-94-0 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2136 - 2145
  • 8
  • [ 504-29-0 ]
  • [ 34619-03-9 ]
  • [ 75-65-0 ]
  • [ 38427-94-0 ]
Reference: [1] Patent: US2010/105737, 2010, A1, . Location in patent: Page/Page column 16
  • 9
  • [ 504-29-0 ]
  • [ 24608-52-4 ]
  • [ 38427-94-0 ]
Reference: [1] Journal of Organic Chemistry, 2017, vol. 82, # 18, p. 9410 - 9417
  • 10
  • [ 109-04-6 ]
  • [ 38427-94-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1994, vol. 131, # 4, p. 429 - 433
  • 11
  • [ 38427-94-0 ]
  • [ 6188-43-8 ]
Reference: [1] Chemical Communications, 2011, vol. 47, # 17, p. 5043 - 5045
[2] Chemical Communications, 2011, vol. 47, # 17, p. 5043 - 5045
[3] Chemical Communications, 2011, vol. 47, # 17, p. 5043 - 5045
[4] European Journal of Organic Chemistry, 2013, # 1, p. 35 - 39
[5] European Journal of Organic Chemistry, 2013, # 1, p. 35 - 39
[6] European Journal of Organic Chemistry, 2013, # 1, p. 35 - 39
[7] European Journal of Organic Chemistry, 2013, # 1, p. 35 - 39
  • 12
  • [ 38427-94-0 ]
  • [ 68-12-2 ]
  • [ 116026-94-9 ]
YieldReaction ConditionsOperation in experiment
52%
Stage #1: With tert.-butyl lithium In diethyl ether at -78 - 0℃; for 1 h; Inert atmosphere
Stage #2: at 0℃; for 0.166667 h;
Step 2: tert-Butyl 3-formylpyridin-2-ylcarbamate (9b)To a solution of compound 9a (14.0 g, 72 mmol) in Et20 (500 mL) was added tert-BuLi (1.7M, 106 mL, 180 mmol) at -78°C under N2 atmosphere and the resulting mixture was warmed to 0°C and stirred for 1 h. Anhydrous DMF (8.0 mL, 103 mmol) was added with rapid stirring. The mixture was stirred at 0°C for 10 min, then quenched with half -saturated aq. NH4CI solution. The aqueous layer was extracted with EA twice, the combined organic layers were dried over Na2S04 and concentrated under reduced pressure. The residue was purified by CC (PE/EA = 3/1) to give compound 9b (8.0 g, 52percent) as a white solid.
Reference: [1] Patent: WO2013/64231, 2013, A1, . Location in patent: Page/Page column 45
[2] Heterocyclic Communications, 2011, vol. 17, # 1-2, p. 21 - 23
  • 13
  • [ 2591-86-8 ]
  • [ 38427-94-0 ]
  • [ 116026-94-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2136 - 2145
[2] Synthetic Communications, 2004, vol. 34, # 1, p. 109 - 118
  • 14
  • [ 594-19-4 ]
  • [ 38427-94-0 ]
  • [ 68-12-2 ]
  • [ 116026-94-9 ]
Reference: [1] Patent: US6479512, 2002, B1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38427-94-0 ]

Amides

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.94

Chemical Structure| 639091-78-4

[ 639091-78-4 ]

tert-Butyl (4-(aminomethyl)pyridin-2-yl)carbamate

Similarity: 0.94

Chemical Structure| 169280-83-5

[ 169280-83-5 ]

tert-Butyl (5-(hydroxymethyl)pyridin-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 138343-75-6

[ 138343-75-6 ]

2-(N-Boc-Amino)-3-methylpyridine

Similarity: 0.92

Chemical Structure| 322690-31-3

[ 322690-31-3 ]

tert-Butyl 6-aminopyridin-2-ylcarbamate

Similarity: 0.90

Amines

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.94

Chemical Structure| 639091-78-4

[ 639091-78-4 ]

tert-Butyl (4-(aminomethyl)pyridin-2-yl)carbamate

Similarity: 0.94

Chemical Structure| 169280-83-5

[ 169280-83-5 ]

tert-Butyl (5-(hydroxymethyl)pyridin-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 138343-75-6

[ 138343-75-6 ]

2-(N-Boc-Amino)-3-methylpyridine

Similarity: 0.92

Chemical Structure| 322690-31-3

[ 322690-31-3 ]

tert-Butyl 6-aminopyridin-2-ylcarbamate

Similarity: 0.90

Related Parent Nucleus of
[ 38427-94-0 ]

Pyridines

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.94

Chemical Structure| 639091-78-4

[ 639091-78-4 ]

tert-Butyl (4-(aminomethyl)pyridin-2-yl)carbamate

Similarity: 0.94

Chemical Structure| 169280-83-5

[ 169280-83-5 ]

tert-Butyl (5-(hydroxymethyl)pyridin-2-yl)carbamate

Similarity: 0.92

Chemical Structure| 138343-75-6

[ 138343-75-6 ]

2-(N-Boc-Amino)-3-methylpyridine

Similarity: 0.92

Chemical Structure| 322690-31-3

[ 322690-31-3 ]

tert-Butyl 6-aminopyridin-2-ylcarbamate

Similarity: 0.90